Your browser doesn't support javascript.
loading
Disease-modifying anti-asthmatic drugs.
Lommatzsch, Marek; Brusselle, Guy G; Canonica, G Walter; Jackson, David J; Nair, Parameswaran; Buhl, Roland; Virchow, Johann Christian.
Afiliação
  • Lommatzsch M; Department of Pneumology and Department of Intensive Care Medicine, Universitätsmedizin Rostock, Rostock, Germany. Electronic address: marek.lommatzsch@med.uni-rostock.de.
  • Brusselle GG; Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Canonica GW; Department of Biomedical Sciences, Humanitas University, Asthma & Allergy Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Jackson DJ; Guy's Severe Asthma Centre, School of Immunology & Microbial Sciences, King's College London, London, UK.
  • Nair P; Division of Respirology, Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Buhl R; Pulmonary Department, Mainz University Hospital, Mainz, Germany.
  • Virchow JC; Department of Pneumology and Department of Intensive Care Medicine, Universitätsmedizin Rostock, Rostock, Germany.
Lancet ; 399(10335): 1664-1668, 2022 04 23.
Article em En | MEDLINE | ID: mdl-35461560

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article